Health : Medical Research (Grantmaking/Grants Payable)

Damon Runyon Cancer Research Foundation

Funding brave and bold.

92.61

One Exchange Plaza 55 Broadway, Suite 302
New York, NY 10006
tel: (877) 722-6237   Web Site
EIN: 13-1933825

Board Leadership
Deborah J. Coleman
Chair

CEO
Yung S. Lie
President and CEO

  Score
(out of 100)
Rating
Overall Score & Rating 92.61
  Financial 89.55
  Accountability & Transparency 100.00
This rating was published 04/01/2021 and includes data from FY2019, the most recent 990 received at that time.

At Damon Runyon Cancer Research Foundation, we raise money for high-risk, high-reward cancer research done by brilliant young scientists who are willing to push boundaries and break rules. In other words, we fund brave and bold. Because only by being brave and bold, by risking failure, are we going to achieve real and lasting success against a foe as complex, resilient, and deadly as cancer.

Since our founding in 1946, in partnership with donors across the nation, we have invested over $400 million and funded over 3,850 scientists. Damon Runyon cancer researchers have made extraordinary breakthroughs in every area of cancer prevention, diagnosis, and treatment. To this day, we support the next generation of leaders: emerging talent with unique insights, drive, and boundless vision. We will not stop until we have the tools to prevent or cure all cancers.

At Damon Runyon Cancer Research Foundation, we raise money for high-risk, high-reward cancer research done by brilliant young scientists who are willing to push boundaries and break rules. In other words, we fund brave and bold. Because only by being brave and bold, by risking failure, are we going to achieve real and lasting success against a foe as complex, resilient, and deadly as cancer.

Since our founding in 1946, in partnership with donors across the nation, we have invested over $400 million and funded over 3,850 scientists. Damon Runyon cancer researchers have made extraordinary breakthroughs in every area of cancer prevention, diagnosis, and treatment. To this day, we support the next generation of leaders: emerging talent with unique insights, drive, and boundless vision. We will not stop until we have the tools to prevent or cure all cancers.

Financial

89.55

Accountability & Transparency

100.00

This rating was published 04/01/2021 and includes data from FY2019, the most recent 990 received at that time.
Overall Rating Chart
  Program Expenses
(Percent of the charity's total expenses spent on the programs
and services it delivers)
86.1%
  Administrative Expenses 2.8%
  Fundraising Expenses 10.9%
  Fundraising Efficiency $0.20
  Working Capital Ratio (years) 4.96
  Program Expenses Growth 5.1%
  Liabilities to Assets 23.5%
All data for Financial Performance Metrics calculations was provided by Damon Runyon Cancer Research Foundation on recent 990s filed with the IRS.
All data for Financial Performance Metrics calculations was provided by Damon Runyon Cancer Research Foundation on recent 990s filed with the IRS.
REVENUE  
Contributions  
   Contributions, Gifts & Grants $9,220,131
   Federated Campaigns $0
   Membership Dues $0
   Fundraising Events $1,731,019
   Related Organizations $0
   Government Grants $0
Total Contributions $10,951,150
   Program Service Revenue $0
Total Primary Revenue $10,951,150
   Other Revenue $10,054,133
TOTAL REVENUE $21,005,283
   
EXPENSES  
   Program Expenses $21,997,952
   Administrative Expenses $767,152
   Fundraising Expenses $2,535,993
TOTAL FUNCTIONAL EXPENSES $25,301,097
   
Payments to Affiliates $0
Excess (or Deficit) for the year $-4,295,814
   
Net Assets $115,018,044

Charts

Compensation % of Expenses Paid to Title
$304,731 1.20% Yung Lie President & CEO
Other Salaries of Note
$539,070 2.13% Lorraine W. Egan Former President & CEO

Mission

At Damon Runyon Cancer Research Foundation, we raise money for high-risk, high-reward cancer research done by brilliant young scientists who are willing to push boundaries and break rules. In other words, we fund brave and bold. Because only by being brave and bold, by risking failure, are we going to achieve real and lasting success against a foe as complex, resilient, and deadly as cancer.

Since our founding in 1946, in partnership with donors across the nation, we have invested over $400 million and funded over 3,850 scientists. Damon Runyon cancer researchers have made extraordinary breakthroughs in every area of cancer prevention, diagnosis, and treatment. To this day, we support the next generation of leaders: emerging talent with unique insights, drive, and boundless vision. We will not stop until we have the tools to prevent or cure all cancers.

Highly Rated

Charity Name & State Overall Score Overall Rating
Damon Runyon Cancer Research Foundation (NY) 92.61
International Waldenstrom's Macroglobulinemia Foundation (FL) 95.47
Rally Foundation (GA) 94.69
Cancer Research Institute (NY) 93.60
Dana-Farber Cancer Institute (MA) 93.91

Compare These Charities (Highly Rated)

Charity Contact Info

Damon Runyon Cancer Research Foundation
One Exchange Plaza
55 Broadway, Suite 302
New York, NY 10006
tel: (877) 722-6237
fax: (212) 455-0509
EIN: 13-1933825

Visit Web Site

Board Leadership

Deborah J. Coleman
Chair

CEO

Yung S. Lie
President and CEO